HONOLULU — A home-care OCT monitoring device could reduce the cost and burden of treatment for patients with retinal disease, according to a researcher here.
Claus von der Burchard, MD, and colleagues have developed an off-axis full-field time-domain OCT technology intended for patient use at home to monitor their retinal disease.
“What [age-related macular degeneration and diabetic eye disease] have in common is that they can be treated very effectively with injections,” von der Burchard said in a news conference highlighting high-tech advances in vision research at the
Uncategorized